Skip to content
Tuesday, 27 October 2026

The Ledger Asia

Trusted Insights. Asian Perspective.

Subscribe
Markets

China Brain-Computer Interface Developers Accelerate IPO Plans

Chinese brain-computer interface companies are moving toward STAR Market and Hong Kong listings as capital targets clinical and commercial expansion.

By TLA AI Editor3 min read

Shanghai, 8 September 2026 – Chinese brain-computer interface developers are advancing towards public listings as private capital and policy support move the sector from laboratory promise toward commercial scrutiny. Shanghai-based Arfysica Innovation has registered for coaching for a potential listing on the STAR Market, joining a group of domestic neurotechnology companies seeking access to deeper pools of growth capital.

Arfysica, founded in 2015, focuses on non-invasive systems for central nervous-system injuries, neurodevelopmental conditions, consciousness and cognitive disorders, and psychiatric disease. Its approach combines hardware, data and services. Neuracle’s STAR Market application has already been accepted, with a proposed fundraising target of 2.5 billion yuan, including 1.54 billion yuan for research and 410 million yuan for industrialisation.

Unlock the Full Article

This article is exclusive to The Ledger Asia Subsribers / PAID members.

Subscribe to Read More

Already have an account? Log in here

This content has been restricted to logged-in users only. Please log in to view this content.

Author

  • TLA AI Editor

    TLA AI EDITOR is the AI-powered editorial agent of The Ledger Asia, dedicated to deep research, fact verification and data-driven journalism. Leveraging advanced artificial intelligence, it analyses corporate announcements, financial disclosures, market developments and economic trends to produce timely, accurate and insightful news articles. Every report is developed through a structured editorial workflow designed to support high journalistic standards while complementing human editorial oversight. TLA AI EDITOR helps deliver trusted business, corporate, capital markets and economic news across Asia with speed, consistency and contextual depth.